← Every company
Insmed Inc Patents
What Insmed Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
INSM on carbonthat →Filings on file
51
Granted
4
Still pending
47
Filed under
2 names
51 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOFA61P 9/10, C07D 263/58, A61P 17/06, A61P 11/06, A61P 11/00, A61P 35/00, A61K 31/397, A61K 31/423, A61K 31/427, A61K 31/4439, C07D 205/04, C07D 209/34, C07D 221/20, C07D 231/56, C07D 241/42, C07D 249/18, C07D 295/155, C07D 309/14, C07D 311/80, C07D 401/04, C07D 401/14, C07D 407/04, C07D 413/12, C07D 417/12, C07D 471/04, C07D 471/10, C07D 487/04, C07D 491/107, C07D 491/20, C07D 498/04Filed as Insmed Incorporated2026-05-15Adam J. PLAUNT | pending |
| USES OF DPP1 INHIBITORSFiled as INSMED INCORPORATED2026-01-15ADAM J. PLAUNT | pending |
| DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOFFiled as INSMED INCORPORATED2026-01-05ADAM J. PLAUNT | pending |
| DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOFFiled as INSMED INCORPORATED2025-12-15ADAM J. PLAUNT | pending |
| LARGE-SCALE MANUFACTURING METHODS FOR AMINOGLYCOSIDESA61K 9/127, A61K 9/1277, A61K 31/7036, A61K 47/14, A61K 47/24, A61K 47/26, A61K 47/28Filed as Insmed Incorporated2025-12-09Robert WORSHAM | pending |
| SYNTHESIS OF (2S)-N-((1S)-1-CYANO-2-(4-(3-METHYL-2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-5-YL)PHENYL)ETHYL)-1,4-OXAZEPANE-2-CARBOXAMIDEFiled as INSMED INCORPORATED2025-11-14MONTSERRAT FAJA GENOVÉS | pending |
| PASYLATED URICASE VARIANTS AND METHODS OF USE THEREOFFiled as INSMED INCORPORATED2025-11-05CHRIS BAILEY-KELLOGG | pending |
| URICASE VARIANTS AND METHODS OF USE THEREOFFiled as INSMED INCORPORATED2025-11-05CHRIS BAILEY-KELLOGG | pending |
| NANNOCHLOROPSIS-PRODUCING VIRUSES AND METHODS AND COMPOSITIONS FOR MAKING THE SAMEC07K 14/005, C12N 1/12, C12N 15/79, C12R2001/89, A61K 39/23, A61K 48/0058, A61K 48/0091, C07K 14/015, C12N 15/86, C12N 15/8645, C12N2750/14132, C12N2750/14134, C12N2750/14143, C12N2750/14151, C12N2750/14152, C12N2830/34, C12P 21/02Filed as Insmed Incorporated2025-10-31Anthony BERNDT | pending |
| URICASE VARIANTS AND METHODS OF USE THEREOFC12N 9/0048, A61P 19/06, A61K 9/0019, A61K 38/00, C07K2319/21, C07K2319/31, C12Y 107/03003Filed as Insmed Incorporated2025-10-31Chris BAILEY-KELLOGG | pending |
| NOVEL URICASE VARIANTS AND METHODS OF USE THEREOFC12N 9/0048, A61K 38/00, C12Y 107/03003Filed as Insmed Incorporated2025-10-31Chris BAILEY-KELLOGG | pending |
| ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF USE THEREOFA61P 17/00, C07K 16/24, A61P 11/06, A61P 11/00, A61K 39/00, A61K2039/505, A61K2039/507, A61K2039/545, C07K2317/24, C07K2317/34, C07K2317/56, C07K2317/76, C07K2317/92Filed as Insmed Incorporated2025-10-23Martin PHILLIPS | pending |
| METHODS FOR TREATING NEWLY DIAGNOSED MYCOBACTERIUM AVIUM COMPLEX LUNG INFECTIONSA61K 9/127, A61K 31/7036, A61P 31/04, A61K 9/0078, A61K 31/133, A61K 31/7048, A61K 31/7052, A61K2300/00Filed as Insmed Incorporated2025-10-10Kevin MANGE | pending |
| LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOFA61K 31/496, A61M 11/001, A61M 11/006, A61P 31/00, A61P 31/12, A61P 11/08, A61P 31/08, Y02A 50/30, A61P 31/04, A61P 11/00, A61P 31/06, A61P 31/10, A61K 9/0073, A61K 9/0078, A61K 9/008, A61K 9/127, A61K 9/14, A61K 31/7034, A61K 31/7036, A61K 31/7048, A61K 45/06, A61K 47/26, A61M 11/005, A61M 11/02, A61M 15/009, A61M 15/0091, A61M 15/08Filed as Insmed Incorporated2025-09-26Jeff WEERS | pending |
| DPP1 INHIBITORS WITH POLYCYCLIC LINKERS AND USES THEREOFA61P 9/04, A61P 11/00, C07D 267/10, A61P 37/00, A61P 11/06, A61P 19/02, A61P 29/00, A61P 35/04, A61P 1/04, A61P 35/00, A61K 31/55, A61K 31/553, C07D 223/04, C07D 413/12, C07D 413/14, C07D 417/14, C07D 493/04, C07D 495/04, C07D 513/04, C07D 517/04Filed as Insmed Incorporated2025-09-15Adam J. PLAUNT | pending |
| SPRAY DRIED TREPROSTINIL FORMULATIONFiled as Insmed Incorporated2025-09-15David CIPOLLA | pending |
| DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOFC07D 267/22, C07D 413/12, A61P 11/00, C07D 267/10, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/04, C07D 491/107, C07D 491/14, C07D 491/20, C07D 495/04, C07D 495/10, C07D 498/04, C07D 513/04, C07D 519/00Filed as Insmed Incorporated2025-09-10Adam J. PLAUNT | pending |
| LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOFA61P 9/10, C07D 263/58, A61P 17/06, A61P 11/06, A61P 11/00, A61P 35/00, A61K 31/397, A61K 31/423, A61K 31/427, A61K 31/4439, C07D 205/04, C07D 209/34, C07D 221/20, C07D 231/56, C07D 241/42, C07D 249/18, C07D 295/155, C07D 309/14, C07D 311/80, C07D 401/04, C07D 401/14, C07D 407/04, C07D 413/12, C07D 417/12, C07D 471/04, C07D 471/10, C07D 487/04, C07D 491/107, C07D 491/20, C07D 498/04Filed as Insmed Incorporated2025-09-09Adam J. PLAUNT | 12679815 |
| NOVEL, REVERSIBLE DPP1 INHIBITORS AND USES THEREOFA61P 11/06, C07D 413/12, A61P 11/08, A61P 17/00, A61P 19/02, A61P 9/12, A61P 13/12, A61P 1/00, A61P 11/00, A61P 29/00, A61P 35/04, A61P 11/02, A61K 31/553, C07D 267/22, C07D 413/14, C07D 417/14, C07D 491/107, C07D 498/10Filed as Insmed Incorporated2025-08-28Adam J. PLAUNT | pending |
| PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOFA61K 47/6929, C07C 69/734, C07C 235/22, C07C2601/18, C07C2603/14, A61K 47/6907, A61K 47/543, A61K 47/544, A61K 47/60, A61P 9/12, A61P 11/00, A61K 9/0019, A61K 9/0043, A61K 9/0053, A61K 9/0073, A61K 9/0075, A61K 9/0078, A61K 9/10, A61K 9/14, A61K 9/51, A61K 31/165, A61K 31/216, A61K 31/225, A61K 31/5585, A61K 47/06, A61K 47/14, A61K 47/24, A61K 47/28, A61K 47/34, A61M 15/0085, A61M 15/009, A61M 16/14, A61M2202/064, C07C 69/712, C07C 69/736, C07C 69/753, C07C 235/20Filed as Insmed Incorporated2025-08-19Vladimir MALININ | pending |
| USES OF CERTAIN 1,4-OXAZEPANE-2-CARBOXAMIDES AS DPP1 INHIBITORSA61K 31/553, C07D 413/12, A61P 11/00, C07D 267/10, C07D 413/14, C07D 417/12Filed as Insmed Incorporated2025-08-13Adam J. PLAUNT | pending |
| ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF BLOCKING THE INTERACTION BETWEEN SCF AND c-KITA61P 11/06, C07K 16/24, A61P 37/08, A61P 11/00, A61P 29/00, A61K2039/505, C07K2317/24, C07K2317/33, C07K2317/34, C07K2317/56, C07K2317/565, C07K2317/76, C07K2317/77, C07K2317/92, C12N 15/63Filed as Insmed Incorporated2025-08-06Martin PHILLIPS | pending |
| METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONSA61K 9/127, A61K 31/7036, A61P 31/04, A61K 9/0019, A61K 9/0053, A61K 9/0078, A61K 31/133, A61K 31/407, A61K 31/4375, A61K 31/438, A61K 31/4409, A61K 31/4709, A61K 31/496, A61K 31/5383, A61K 31/546, A61K 31/65, A61K 31/7048, A61K 31/7052, A61K 45/06, A61K2300/00Filed as Insmed Incorporated2025-07-02Gina EAGLE | pending |
| USES OF CERTAIN CARBOXAMIDES AS DPP1 INHIBITORSFiled as INSMED INCORPORATED2025-06-11ADAM J. PLAUNT | pending |
| URICASE CONJUGATES AND METHODS OF USE THEREOFC12N 9/0048, C12Y 107/03003, A61P 19/06, A61P 35/00, A61K 9/0019, A61K 38/00, C07K2319/00Filed as Insmed Incorporated2025-06-06Patrick WIENCEK | pending |
| METHODS FOR TREATING BRONCHIECTASISFiled as INSMED INCORPORATED2025-05-27CARLOS FERNANDEZ | pending |
| COMPOSITIONS AND METHODS FOR TREATING STARGARDT DISEASEFiled as INSMED INCORPORATED2025-05-02LUKAS CHRISTOPH BACHMANN | pending |
| DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOFFiled as INSMED INCORPORATED2025-04-11ADAM J. PLAUNT | pending |
| METHODS FOR CONTINUOUS MANUFACTURE OF LIPOSOMAL DRUG PRODUCTSB01F 23/41, A61K 9/1277, B01F 23/49, B01F 23/4105, B01F2101/22, A61K 31/145, A61K 31/4174, A61K 31/4196, A61K 31/42, A61K 31/4375, A61K 31/496, A61K 31/5025, A61K 31/505, A61K 31/65, A61K 31/7036, A61K 31/7048, A61K 38/14Filed as Insmed Incorporated2025-03-27Robert WORSHAM | pending |
| REVERSIBLE DPP1 INHIBITORS AND USES THEREOFA61P 11/06, C07D 413/12, A61P 11/08, A61P 17/00, A61P 19/02, A61P 9/12, A61P 13/12, A61P 1/00, A61P 11/00, A61P 29/00, A61P 35/04, A61P 11/02, A61K 31/553, C07D 267/22, C07D 413/14, C07D 417/14, C07D 491/107, C07D 498/10Filed as Insmed Incorporated2025-03-24Adam J. PLAUNT | 12479837 |
| DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOFFiled as INSMED INCORPORATED2025-01-29ADAM J. PLAUNT | pending |
| NOVEL DPP1 INHIBITORS AND USES THEREOFC07D 413/12, C07D 491/107, A61P 29/00, A61K 31/397, A61K 31/403, A61K 31/423, A61K 31/437, A61K 31/439, A61K 31/4439, A61K 31/454, A61K 31/496, A61K 31/5377, A61K 31/5386, A61K 31/541, A61K 31/553, A61K 31/554, C07B 59/002, C07B2200/05, C07D 205/04, C07D 209/52, C07D 263/58, C07D 267/10, C07D 409/12, C07D 413/14, C07D 417/12, C07D 419/12, C07D 453/02, C07D 471/04, C07D 487/08, C07D 491/04, C07D 491/048, C07D 493/08, C07D 497/10Filed as Insmed Incorporated2025-01-22Adam J. PLAUNT | pending |
| METHODS OF MANUFACTURING TREPROSTINIL AND TREPROSTINIL DERIVATIVE PRODRUGSC07C 231/02, C07C2601/18, C07C2602/24, C07C 67/08, C07C 235/06, C07C 235/12, C07C 235/14, C07C 69/712Filed as Insmed Incorporated2025-01-17Vladimir MALININ | pending |
| CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING BRONCHIECTASISA61K 31/553, A61P 11/08, A61P 31/04, A61P 11/00, A61K 9/0053Filed as Insmed Incorporated2025-01-16Hans Roland LONN | pending |
| USES OF DPP1 INHIBITORSFiled as Insmed Incorporated2025-01-16Adam J. PLAUNT | pending |
| DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOFFiled as Insmed Incorporated2025-01-03Adam J. PLAUNT | pending |
| METHODS OF TREATMENT USING DRY POWDER COMPOSITIONS OF TREPROSTINIL PRODRUGSFiled as INSMED INCORPORATED2025-01-03ARIEL TEPER | pending |
| DRY POWDER COMPOSITIONS OF TREPROSTINIL PRODRUGS AND METHODS OF USE THEREOFA61K 9/0075, A61K 9/146, A61K 9/1617, A61P 9/12, A61K 9/145, A61K 9/1623, A61K 31/198, A61K 31/216, A61K 31/5575, A61K 31/5578, A61K 47/183Filed as Insmed Incorporated2024-12-09Ju DU | pending |
| METHODS OF TREATMENT USING DRY POWDER COMPOSITIONS OF TREPROSTINIL PRODRUGSFiled as Insmed Incorporated2024-11-22Gerald O’BRIEN | pending |
| METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONSA61K 9/127, A61K 31/7036, A61P 31/04, A61K 9/0019, A61K 9/0053, A61K 9/0078, A61K 31/133, A61K 31/407, A61K 31/4375, A61K 31/438, A61K 31/4409, A61K 31/4709, A61K 31/496, A61K 31/5383, A61K 31/546, A61K 31/65, A61K 31/7048, A61K 31/7052, A61K 45/06, A61K2300/00Filed as Insmed Incorporated2024-11-07Gina EAGLE | 12616708 |
| URICASE VARIANTS AND METHODS OF USE THEREOFFiled as Insmed Incorporated2024-11-06Chris BAILEY-KELLOGG | pending |
| MEDICAMENT DELIVERY DEVICE, COVER, AND METHODS OF MEDICAMENT DELIVERYFiled as INSMED INCORPORATED2024-10-30JUNG SOO PARK | pending |
| METHODS OF TREATMENT USING DRY POWDER COMPOSITIONS OF TREPROSTINIL PRODRUGSFiled as Insmed Incorporated2024-10-30Gerald O’BRIEN | pending |
| METHODS FOR TREATING BRONCHIECTASISFiled as Insmed Incorporated2024-10-28Carlos FERNANDEZ | pending |
| COMPOSITIONS AND METHODS FOR TREATING STARGARDT DISEASEFiled as Insmed Incorporated2024-10-10Lukas Christoph BACHMANN | pending |
| DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOFFiled as INSMED INCORPORATED2024-09-13ADAM J. PLAUNT | pending |
| LARGE-SCALE MANUFACTURING METHODS FOR AMINOGLYCOSIDESA61K 9/127, A61K 9/1277, A61K 31/7036, A61K 47/14, A61K 47/24, A61K 47/26, A61K 47/28Filed as Insmed Incorporated2024-09-05Robert WORSHAM | 12521345 |
| CERTAIN N-(1-CYAN0-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING HIDRADENITIS SUPPURATIVAA61P 29/00, A61K 31/553, A61P 17/00, A61K 9/0053, A61K 45/06Filed as Insmed Incorporated2024-08-15Ariel TEPER | pending |
| DRY POWDER COMPOSITIONS OF BEDAQUILINE AND SALTS AND METHODS OF USE THEREOFA61K 9/0075, A61K 31/47, A61P 31/04, A61P 35/04, A61P 31/06, A61P 35/00, A61K 9/1617, A61K 47/183Filed as Insmed Incorporated2024-08-06Sachin GHARSE | pending |
| NOVEL IGG PROTEASES AND METHODS OF USE THEREOFFiled as INSMED INCORPORATED2024-08-01SPENCER MITCHELL | pending |
| DEIMMUNIZED LYSOSTAPHIN AND METHODS OF USEC12N 9/52, A61P 43/00, A61P 31/04, A61K 31/18, A61K 31/397, A61K 31/47, A61K 31/519, A61K 31/545, A61K 31/7036, A61K 31/7048, A61K 38/00, A61K 38/48, A61K 38/4886, A61K 45/06, C12Y 304/24075, A61K2300/00Filed as INSMED INCORPORATED2024-07-29Karl E. GRISWOLD | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.
More on INSM
Company overviewEverything on INSM in one place, with the price.SEC filingsWhat INSM's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat INSM's own officers and directors buy and sell.Who owns itEvery manager reporting a position in INSM.Funds holding itWhich funds and ETFs hold INSM, and how big a bet.LobbyingWhat INSM spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on INSM's account, and who they worked for.Federal contractsWhat federal agencies pay INSM.